Renaissance Investment Group buys $6,401,140 stake in Danaher Corporation (DHR)

Danaher Corporation (DHR) : Renaissance Investment Group scooped up 995 additional shares in Danaher Corporation during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Jul 14, 2016. The investment management firm now holds a total of 79,085 shares of Danaher Corporation which is valued at $6,401,140.Danaher Corporation makes up approximately 3.06% of Renaissance Investment Group’s portfolio.

Other Hedge Funds, Including , Rosenbaum Jay D. added DHR to its portfolio by purchasing 2,745 company shares during the most recent quarter which is valued at $221,961. Danaher Corporation makes up approx 0.03% of Rosenbaum Jay D.’s portfolio.Washington Trust Bank boosted its stake in DHR in the latest quarter, The investment management firm added 915 additional shares and now holds a total of 1,950 shares of Danaher Corporation which is valued at $157,677. Danaher Corporation makes up approx 0.04% of Washington Trust Bank’s portfolio.Nexus Investment Management reduced its stake in DHR by selling 100 shares or 0.42% in the most recent quarter. The Hedge Fund company now holds 23,950 shares of DHR which is valued at $1,936,597. Danaher Corporation makes up approx 0.36% of Nexus Investment Management’s portfolio.Bnp Paribas Arbitrage Sa reduced its stake in DHR by selling 63,179 shares or 22.73% in the most recent quarter. The Hedge Fund company now holds 214,716 shares of DHR which is valued at $17,361,936. Danaher Corporation makes up approx 0.08% of Bnp Paribas Arbitrage Sa’s portfolio.

Danaher Corporation opened for trading at $81.02 and hit $81.58 on the upside on Monday, eventually ending the session at $80.94, with a gain of 0.02% or 0.02 points. The heightened volatility saw the trading volume jump to 23,41,632 shares. Company has a market cap of $55,743 M.

On the company’s financial health, Danaher Corporation reported $1.08 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on Apr 21, 2016. Analyst had a consensus of $1.03. The company had revenue of $5387.20 million for the quarter, compared to analysts expectations of $5329.83 million. The company’s revenue was up 14.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.93 EPS.

Many Wall Street Analysts have commented on Danaher Corporation. Shares were Reiterated by Barclays on Jul 11, 2016 to “Overweight” and Lowered the Price Target to $ 86 from a previous price target of $105 .Danaher Corporation was Initiated by Goldman to “Neutral” on Jul 5, 2016. Danaher Corporation was Upgraded by Bernstein to ” Outperform” on Jun 24, 2016.

Danaher Corporation (Danaher) designs manufactures and markets professional medical industrial and commercial products and services. It operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental and Industrial Technologies. The Test & Measurement segment offers test measurement and monitoring products. The Environmental segment products and services help protect the global water supply facilitate environmental stewardship and enhance the safety of personal data. The Company’s diagnostics business offers analytical instruments reagents consumables software and services. The Dental segment provides products that are used to diagnose treat and prevent disease and ailments of the teeth gums and supporting bone. The Company’s Industrial Technologies solutions help protect the world’s food supply improve packaging design and quality verify pharmaceutical dosages and authenticity and power innovative machines.

Leave a Reply

Danaher Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Danaher Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.